The role of lncRNA OIP5-AS1 in cancer development and progression

[1]  Gengyun Sun,et al.  lncRNA OIP5‐AS1 knockdown or miR‐223 overexpression can alleviate LPS‐induced ALI/ARDS by interfering with miR‐223/NLRP3‐mediated pyroptosis , 2021, The journal of gene medicine.

[2]  Yun Liu,et al.  lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p , 2021, Journal of immunology research.

[3]  Zhi-wei Wang,et al.  Targeting cancer stem cells by nutraceuticals for cancer therapy. , 2021, Seminars in cancer biology.

[4]  Zhixi Chen,et al.  Long non-coding RNA OIP5-AS1 promotes the progression of esophageal cancer by regulating miR-30a/VOPP1 expression , 2021, Oncology Letters.

[5]  M. Fabbri,et al.  Noncoding RNA therapeutics — challenges and potential solutions , 2021, Nature reviews. Drug discovery.

[6]  J. Lathia,et al.  Cancer stem cell–immune cell crosstalk in tumour progression , 2021, Nature Reviews Cancer.

[7]  Dan Li,et al.  METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer , 2021, Cell Death & Disease.

[8]  Xiaojiang Li,et al.  LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling. , 2021, Ecotoxicology and environmental safety.

[9]  Yan Wang,et al.  Molecular mechanism of miR-34b-5p and RNA binding protein HuR binding to lncRNA OIP5-AS1 in colon cancer cells , 2021, Cancer Gene Therapy.

[10]  C. Maher,et al.  Long noncoding RNAs in cancer metastasis , 2021, Nature Reviews Cancer.

[11]  R. Weinberg,et al.  Linking EMT programmes to normal and neoplastic epithelial stem cells , 2021, Nature Reviews Cancer.

[12]  Ang Li,et al.  Downregulation of OIP5-AS1 affects proNGF-induced pancreatic cancer metastasis by inhibiting p75NTR levels , 2021, Aging.

[13]  S. Pang,et al.  Long noncoding RNA OIP5-AS1 exhibits oncogenic activity in bladder cancer through miR-217 and MTDH. , 2021, European review for medical and pharmacological sciences.

[14]  D. Green,et al.  Autophagy in tumour immunity and therapy , 2021, Nature Reviews Cancer.

[15]  Xiaoming Fu,et al.  Long non-coding RNA OIP5-AS1 facilitates the progression of ovarian cancer via the miR-128-3p/CCNG1 axis , 2021, Molecular Medicine Reports.

[16]  Min Lu,et al.  Silencing of OIP5-AS1 Protects Endothelial Cells From ox-LDL-Triggered Injury by Regulating KLF5 Expression via Sponging miR-135a-5p , 2021, Frontiers in Cardiovascular Medicine.

[17]  Xing Liu,et al.  Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer , 2021, Bosnian journal of basic medical sciences.

[18]  Zhen Xiao,et al.  Long non-coding RNA OIP5-AS1 contributes to cisplatin resistance of oral squamous cell carcinoma through the miR-27b-3p/TRIM14 axis , 2021, Experimental and Therapeutic Medicine.

[19]  M. Taheri,et al.  A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  Jian-jun Tang,et al.  Long Noncoding RNA OIP5-AS1 Promotes the Disease Progression in Nasopharyngeal Carcinoma by Targeting miR-203 , 2021, BioMed research international.

[21]  W. Shao,et al.  OIP5-AS1 specifies p53-driven POX transcription regulated by TRPC6 in glioma , 2021, Journal of molecular cell biology.

[22]  Weihua Liu,et al.  Up-regulating lncRNA OIP5-AS1 protects neuron injury against cerebral hypoxia-ischemia induced inflammation and oxidative stress in microglia/macrophage through activating CTRP3 via sponging miR-186-5p. , 2021, International immunopharmacology.

[23]  S. Peng,et al.  Exosomal-mediated transfer of OIP5-AS1 enhanced cell chemoresistance to trastuzumab in breast cancer via up-regulating HMGB3 by sponging miR-381-3p , 2021, Open medicine.

[24]  Zhiwei Song,et al.  LncRNA OIP5-AS1 reduces α-synuclein aggregation and toxicity by targeting miR-126 to activate PLK2 in human neuroblastoma SH-SY5Y cells , 2020, Neuroscience Letters.

[25]  Y. Kotake,et al.  OIP5-AS1 Promotes Proliferation of Non-small-cell Lung Cancer and Head and Neck Squamous Cell Carcinoma Cells , 2021, Cancer Genomics & Proteomics.

[26]  Song Wang,et al.  Highly enriched exosomal lncRNA OIP5-AS1 regulates osteosarcoma tumor angiogenesis and autophagy through miR-153 and ATG5. , 2021, American journal of translational research.

[27]  Jing Li,et al.  Long Non-Coding RNA OIP5-AS1 Contributes to Gallbladder Cancer Cell Invasion and Migration by miR-143-3p Suppression , 2020, Cancer management and research.

[28]  B. Kong,et al.  PBK promotes aggressive phenotypes of cervical cancer through ERK/c‐Myc signaling pathway , 2020, Journal of cellular physiology.

[29]  Q. Fang,et al.  LncRNA OIP5-AS1 upregulates snail expression by sponging miR-34a to promote ovarian carcinoma cell invasion and migration , 2020, Biological research.

[30]  Guanglin Zhang,et al.  LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis , 2020, Molecular and cellular biochemistry.

[31]  Yinfeng Liu,et al.  LncRNA OIP5-AS1 Promotes Breast Cancer Progression by Regulating miR-216a-5p/GLO1. , 2020, The Journal of surgical research.

[32]  Dong Liu,et al.  OIP5-AS1/miR-137/ZNF217 Axis Promotes Malignant Behaviors in Epithelial Ovarian Cancer , 2020, Cancer management and research.

[33]  Dan Yang,et al.  OIP5-AS1 modulates epigenetic regulator HDAC7 to enhance non-small cell lung cancer metastasis via miR-140-5p , 2020, Oncology letters.

[34]  Y. Shao,et al.  LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway , 2020, Cancer Cell International.

[35]  X-X Jiang,et al.  Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis. , 2020, European review for medical and pharmacological sciences.

[36]  Yushui Ma,et al.  Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis , 2020, Molecular therapy. Nucleic acids.

[37]  D. Min,et al.  Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[38]  Jian Huang,et al.  Construction and Analysis of a Long Non-Coding RNA-Associated Competing Endogenous RNA Network Identified Potential Prognostic Biomarkers in Luminal Breast Cancer , 2020, OncoTargets and therapy.

[39]  Haibao Wang,et al.  Long non-coding RNA OIP5-AS1 suppresses multiple myeloma progression by sponging miR-27a-3p to activate TSC1 expression , 2020, Cancer Cell International.

[40]  Ling Liu,et al.  Long Non-Coding RNA OIP5-AS1 Knockdown Enhances CDDP Sensitivity in Osteosarcoma via miR-377-3p/FOSL2 Axis , 2020, OncoTargets and therapy.

[41]  Qing Yang,et al.  LncRNA OIP5-AS1 promotes cell proliferation and migration and induces angiogenesis via regulating miR-3163/VEGFA in hepatocellular carcinoma , 2020, Cancer biology & therapy.

[42]  X. Tian,et al.  Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137 , 2020, World journal of gastroenterology.

[43]  Zhen Liu,et al.  Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway , 2020, Journal of Physiology and Biochemistry.

[44]  Yang Hu,et al.  LncRNA OIP5-AS1 facilitates gastric cancer cell growth by targeting the miR-422a/ANO1 axis. , 2020, Acta biochimica et biophysica Sinica.

[45]  Y. Assaraf,et al.  Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs. , 2020, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[46]  Hailing Yang,et al.  LNCRNA OIP5-AS1 regulates oxidative low-density lipoprotein-mediated endothelial cell injury via miR-320a/LOX1 axis , 2020, Molecular and Cellular Biochemistry.

[47]  Jianchu Wang,et al.  LncRNA OIP5-AS1 interacts with miR-363-3p to contribute to hepatocellular carcinoma progression through up-regulation of SOX4 , 2020, Gene Therapy.

[48]  Hui Wang,et al.  Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis , 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.

[49]  M. Taheri,et al.  Expression assessment of a panel of long non-coding RNAs in gastric malignancy. , 2020, Experimental and molecular pathology.

[50]  Yuanyu Wu,et al.  Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/HMGA2 axis. , 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[51]  Caihong Yang,et al.  lncRNA OIP5-AS1 targets ROCK1 to promote cell proliferation and inhibit cell apoptosis through a mechanism involving miR-143-3p in cervical cancer , 2020, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[52]  Zhu-ming Guo,et al.  Upregulation of OIP5-AS1 Predicts Poor Prognosis and Contributes to Thyroid Cancer Cell Proliferation and Migration , 2020, Molecular therapy. Nucleic acids.

[53]  Chenghao Zhang,et al.  Prognostic and clinicopathologic significance of long non-coding RNA opa-interacting protein 5-antisense RNA 1 in multiple human cancers , 2020, Artificial cells, nanomedicine, and biotechnology.

[54]  Sheng Li,et al.  Long noncoding RNA OIP5‐AS1 aggravates cell proliferation, migration in gastric cancer by epigenetically silencing NLRP6 expression via binding EZH2 , 2020, Journal of cellular biochemistry.

[55]  Z. Liu,et al.  Long non-coding RNA OIP5-AS1 promotes proliferation of gastric cancer cells by targeting miR-641. , 2019, European review for medical and pharmacological sciences.

[56]  Yue Ge,et al.  Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[57]  Zhi-wei Wang,et al.  Emerging role of F-box proteins in the regulation of epithelial-mesenchymal transition and stem cells in human cancers , 2019, Stem Cell Research & Therapy.

[58]  Yujie Liu,et al.  Long noncoding RNA OIP5-AS1 accelerates the ox-LDL mediated vascular endothelial cells apoptosis through targeting GSK-3β via recruiting EZH2. , 2019, American journal of translational research.

[59]  Shou-Jiang Gao,et al.  Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1/miR-218-5p network , 2019, PLoS pathogens.

[60]  J. Chen,et al.  Downregulation of long non‐coding RNA Opa interacting protein 5‐antisense RNA 1 inhibits breast cancer progression by targeting sex‐determining region Y‐box 2 by microRNA‐129‐5p upregulation , 2018, Cancer science.

[61]  Pei Li,et al.  Long noncoding RNA OIP5‐AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR‐340‐5p , 2018, Journal of cellular biochemistry.

[62]  Tian Kang,et al.  Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410 , 2018, Bioscience reports.

[63]  Lingfei Huang,et al.  Long noncoding RNA OPA‐interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR‐143‐3p , 2018, Journal of cellular physiology.

[64]  Z. Lei,et al.  Fibronectin‐1 modulated by the long noncoding RNA OIP5‐AS1/miR‐200b‐3p axis contributes to doxorubicin resistance of osteosarcoma cells , 2018, Journal of cellular physiology.

[65]  B. Jiang,et al.  Long noncoding RNA opa‐interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR‐143‐3p in cervical cancer , 2018, Journal of cellular biochemistry.

[66]  M. Taheri,et al.  Expression Analysis of OIP5-AS1 in Non-Small Cell Lung Cancer. , 2018, Klinicka onkologie.

[67]  Yong Xia,et al.  LncRNA OIP5‐AS1 predicts poor prognosis and regulates cell proliferation and apoptosis in bladder cancer , 2018, Journal of cellular biochemistry.

[68]  Hailang Sun,et al.  Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[69]  Maolong Wang,et al.  Long non‐coding RNA OIP5‐AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR‐378a‐3p , 2018, Thoracic cancer.

[70]  G. Hu,et al.  LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells. , 2018, European journal of cell biology.

[71]  F. Liu,et al.  Kockdown of OIP5-AS1 expression inhibits proliferation, metastasis and EMT progress in hepatoblastoma cells through up-regulating miR-186a-5p and down-regulating ZEB1. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[72]  Clement Adebamowo,et al.  Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context , 2018, Cell reports.

[73]  G. Arunkumar,et al.  LncRNA OIP5-AS1 is overexpressed in undifferentiated oral tumors and integrated analysis identifies as a downstream effector of stemness-associated transcription factors , 2018, Scientific Reports.

[74]  Chunfeng Liu,et al.  Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[75]  Ping Wang,et al.  PIWIL3/OIP5-AS1/miR-367-3p/CEBPA feedback loop regulates the biological behavior of glioma cells , 2018, Theranostics.

[76]  A. Kiani,et al.  Expression Analysis of OIP 5-AS 1 in Non-Small Cell Lung Cancer , 2018 .

[77]  Huan Yao,et al.  LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma , 2017, Cell Death & Disease.

[78]  Praveen Sethupathy,et al.  Long Noncoding RNA Moderates MicroRNA Activity to Maintain Self-Renewal in Embryonic Stem Cells , 2017, Stem cell reports.

[79]  C. Wahlestedt.  Targeting long non-coding RNA to therapeutically upregulate gene expression , 2013, Nature Reviews Drug Discovery.

[80]  D. Bartel,et al.  Conserved Function of lincRNAs in Vertebrate Embryonic Development despite Rapid Sequence Evolution , 2011, Cell.